Benefits
Antioxidant defense
The only human study cited here tested Activin, a different company's grape seed proanthocyanidin extract, not FitGrape. It was done in people with systemic sclerosis, a rare autoimmune connective-tissue disease, and it reported lower blood levels of malondialdehyde (an oxidative-stress marker) and of the adhesion molecules ICAM-1, VCAM-1, E-selectin and P-selectin. Those are laboratory markers, not symptoms or health outcomes, and nothing here shows what FitGrape does in a healthy person.
Blood-vessel effects are unproven
This is a proposed idea, not something the cited study measured. That study looked at adhesion molecules in the blood, which are markers researchers track in vessel biology. It did not measure blood flow, blood pressure or any circulation outcome, and it did not test FitGrape.
Cell protection (laboratory finding only)
Grape OPCs act as antioxidants in laboratory tests. Whether taking FitGrape protects cells or tissues in people has not been tested.
Mechanism of action
Proanthocyanidin antioxidants
Grape OPCs can neutralize free radicals in laboratory tests, and researchers think they may help the body's own antioxidant enzymes. This is the proposed explanation for how they might work. It has not been confirmed for FitGrape in people.
Vascular signaling
Grape polyphenols are thought to influence nitric oxide, a signal that helps blood vessels relax. This is a theory drawn from other grape research, not something the single study cited on this page measured.
Clinical trials
A 2002 study of Activin, a grape seed proanthocyanidin extract made by a different company. It is not a study of FitGrape. It measured blood markers of oxidative stress and adhesion molecules. (Kalin et al. 2002, Free Radical Research)
People with systemic sclerosis (scleroderma), a rare autoimmune connective-tissue disease. Not healthy adults.
The extract lowered blood levels of malondialdehyde (an oxidative-stress marker) and of the adhesion molecules ICAM-1, VCAM-1, E-selectin and P-selectin. These are surrogate laboratory markers. The study did not report symptom or clinical outcomes, and the results belong to Activin, not to FitGrape.